Entera Bio (NASDAQ:ENTX) has a cash runway of 18 months as of December 2023. It has reduced its cash burn by 42% over the last year, indicating it's an early stage company still developing its business. The key factor is whether the company will grow its business going forward. For this article, we define cash burn as the amount of cash the company is spending each year to fund its growth.